QID,Question,ACYDBNhKOn-ExY7ipfFgxYguVq0ZAu1IxhnEc4ARYEv07nC0Sia2A4lub4VTJEClBhIL1xU,ACYDBNjC8MoMVJom-cuuktwQoN2yGBlefoUMdupd5MO6TiXgwHX-jFJSRrFwDo7gSvZ2TkY,ACYDBNjkfWpuNT5UmtIRsnCvtHXO-woRSJNxcxeVJQa_reGJWhQfpDBoL5tz9ZbVp0CA344,ACYDBNgvb3MjU1I5fYaGS5X4O-5oNBUWPh5b7vwVW1jk8ZwxHUMNmGO7akGGcMKgob7gbq8,ACYDBNgspIPELllCBG7cHtAL9M9pNUkWKf_28nRtwBM5QEZm12mTWBNYpWB5Q8qjpAwiu1E,ACYDBNiix27mEww_FUU8I_eSaWhbN-9_FMalzqrld8J5QYxktw_z5RnMo56_Y5-0lD1Xjo4,ACYDBNgQN2r6KnISP3n1zEM7TIFIbybPd4yoKrVXX3jmE01x_a3o8aLt-ZM3Pqgb30CJfDg,ACYDBNhRdGI299IBisqFM1yC8gXrcvsvTBhm4IJgNq8yM-cP2OQVgGng-kUNLGo0ltKdaA0,ACYDBNgwtspo_pnu_9-a-8iERmbuNKLmVflFb3FHUmNNJuY2QE87W9I8twprDvW8qdwd8Vs,ACYDBNj7v4CQjXOTnYFVWBMCx1YzYjrv_l_HrTyeqUJ4b_PCzmMb08bn1tis0zrXUM1hstY,ACYDBNgZcduun7LO-L8CJtvuT8HXBXi-IJnPUoGK6XNr83266exoEPWD_iqhDLT0tJjW5Jk,ACYDBNii5BniUZ_uTHMTafAEBY0YIVegRWV8l2Jq82VtESpHHvo6N6z6hLtdxE03W10Syv4,ACYDBNg5_QVfefX8puYA09PUCR42EdiLD8nAvWZbRotBJ2B3ZozJdQKFkoUTgzHklIeICZM,ACYDBNgYjJHybFetkcazvLLSH_DhWX0e7dTq1Vh74W3V8mY9TglQj9zpGMxmyaZgPWExd3w,ACYDBNj3H7hOr9GgX2U0AuYU1mxF2EKTN7X9zvlE19sRTViRXMbExomfRH1SkGdQ4R17Qyk,ACYDBNi5g6u85y32umhBl7s8W_efP8vOyzOndaa3egacVjylxcuy8_oSbHXZg_1WYfHAkZc,ACYDBNjV-dGGgcTORnDgV-abLDqhYSCDeZ44Vcb5czGNjFdCA8QELVG9neJDAfnR1WGmDL4,ACYDBNj2PVFKd5o9cW_bwWXBU9w62ZhGY9FsRZs6ATdz0xd8Tq56qlUXyubUk8SVje5eLmE,ACYDBNh-VQ2Q7IbL4Cyv9c7aDGZEROoS1z95XbSpbhmGWwDVDiZfmD8-k5MoAB7pI9g-xn8,ACYDBNh3vZ6w6uuGc4H1oqAZnIUnoAK6RRQpmY522BDYXUF317yhtf4Vp65oKzWS7W6Pkiw,ACYDBNhAB6mCh7oI-9CkrW1rKwgKeHvrCpTQ4fhoPLDAIsPDKymIErxkO_LcznXN-j3sSqc,ACYDBNg7L8IRHZoVtdONF90UnbL-LbZsUOxhgS9ThgvbGkBbbJuLXJ80skbqBl-3Bfb4LWE,ACYDBNhQp7hvdu_0k7ICeDkvKNNtGU7gso2eWiJpkGYiH1aoBc6_bLrf9l3J7Iqq47WHG0M,ACYDBNg-Mi9rZQBtwKkxYGrILAqiqjb9vOypoH6LrQFUhGJR6YWhFZCvKGBgFZFuHZxpGfs,ACYDBNh3zPCljT0gSQbGoGDra3c-pnuVEGh1YyBdFyTVozTibSlKw8sAMA7WrBkiVhS1s4c,ACYDBNg2aCa9eD7tPZo07OD_dr5cIz0xIQVwnLRpBPq0hu4Bl2aIqiZ1vu3uFrpzW3Hk3KQ,ACYDBNgh-tCTz5RoVUz11jpNSlxUhIWrls63a4WtfNO5bbcyxE9dXYXclnKuwbs0WnI_9EY,ACYDBNiZGFSAz1zLyJwqeQMZQlpdtfX-yWH3caRCCrROD1A7fKCvg6sF07_RZeRvaEBqvwE,ACYDBNitra5mmgq9KQdt5JKBGWilPj7hFbvZW9Wcvqu-89tf-TnvXg43icDmlDrMSZGiVb0,ACYDBNhhr1qXm8VFRPJ6qMIHAyL5EQS-xxq8TIZ2PJgWjjvermfVw-BL9pfWPWofZtwhZZo,ACYDBNjsxcNqc0q8KrPJz2vthQb2bo8H1q9w-Rj5-HOV0I1h0npj4gLhab3zjFD7wbF6A3s,ACYDBNiaOWfYz032WhMQ27-TPXLdU37NTqXu4m3L-99elJwGwu7GxNl02PVU2qdJdyt3MC4,ACYDBNjwMoQ--gHL1qheNy0Ia2EMWiFr8N1xiKzPOmIRSkfCTOQ_Z67ga86VmpUGQZBMlgc,ACYDBNgfI17A2eK_qkyn2A7poXNdnGb3ucYuwD-fKoivxPHsh4tHC1sFN-NcifvtOxTCwzM,ACYDBNgD-v8n4VQkzJ4EerECmtS7-rsCxJKeqnD3CYVXOZ5HoixE-G7MY9l0JVrrX6uD-Bo,ACYDBNi3tGQyObj5RUV1niR6oSLqPxOKM995t0KNO-MRArSa31SVhvbM6IJnN5EPaRqCj_M,ACYDBNh-cao0ufuDJL_xKnLXZYSk8NMof1fomkwUnSWUofJtKqgtLRErmG_oLd3K1H9GWhQ,ACYDBNi0_FMNzOH7KQdmflJcgc8shpuWgmDgUY1XJVnxzH4g-l9l5tshN0PkaL1ZqIraSaQ,ACYDBNi3sTGZVwQd8kDgq7fgR0-0mCgGR1T7dYrRRu3rFKw1tR1gPhXzrP9sW2k_VDDCJpA,ACYDBNhTTNuk0WFE3IL7RZObASHUp5v2Z-uDvT-T7dnKASG0E5Whdf0Kbu3VTI2e7xhR-PM,ACYDBNiKwtTr2YTASB0fH6i84i9t5kBEFh4TxiTM5jv_9nYaJfhV3PoToS4S6K8kaF2CRBs,ACYDBNjmMGm2f2dp9_WTx4RZ3iXvrmUA9qpsSOysAN9jo__oUERvQoxapbs759ZJ-ZPBpCE,ACYDBNhXC7jzW__GutSXgSoZ6RljeV9vRUU0z_SEUPMaiVTA4tVagU11__8RW_lICA8EHM4,ACYDBNgiCeUAx9kVVV1WYEYsWJnKFlN1uTSSopkTJBIECWSEMEqmVaCFDH3HA6_5lKjklLs,ACYDBNi5Bh8tB38tFCr4UEn2yubsVSk_kQ_SvXs1kWnYoF_w73B-8u4m6clOPzHWwjK7tHg,ACYDBNhvslqOIxqDLeOEKK9hJ9148bmskMHtWF31O5e-ch3Pyq9umSUFgCMPEgYjxtMiUAI,ACYDBNgwiBV-XdzBzkr_MiDLEqhEI4LpRCGj41RiGNQN4ylmPIhCQV4LPo44ljXH2GkYFJE,ACYDBNjdbSX2AIugPJU6t2OQKfhZarHp7woztSWKIprx0fsa6bvi53zyVGReTCZfD9asWX4,ACYDBNiKvO8ArCrj7ikKCrbl1yf2UswFkubRAwKHWwDly7KumYtjb9-usf-X3-Et6dNdVik,ACYDBNgZpUQFMFFAtCaB4DyrxgJ8jVPIbabX4wKlVIX14F922e1aoHngTqvCdRLhJ41-RBA,ACYDBNg-c-116BVE4f_JDcT_lOBKvEF7o12tS27lXkBog1VkrAzlqYEN08w-bjKCFb0cgmk,ACYDBNhhIx_xqGfup0LQeRRsjYt2JMa0qC9NdIHQmvgcVn2shV7GsQnrDVXndnZMjlnG0os,ACYDBNjXVbY1v0N18fdhh0zwN1Kr1AY1yFef4RORhAtLlquf_3hdSM1tXQyb0oj-dDr0QJQ,ACYDBNjEyVEcRceG7lccqLGoFH5QbMCUWY2Ie-mrLWC65zodyzI4kuKd6WIsixqIc86T09E,ACYDBNjmpPiIS7MSPpYvyRPMhhI7Ox9vQQ-xYM9tc5EDz7atYXWdlV1QiK5VVui6jt_bimg,ACYDBNh5aJwf809la8aITW64AnXcLEc2KtT6srHWDyN2S_NRqSRGK_gwsOF8lDLHKG9kCQg,ACYDBNiso-xtvG8myHrcs1j12PjopfuOJ-quzTB8jgpqgYVfJ4rDZ2pVJOt6fOIUU3ZYUhc,ACYDBNjLNvEwscBUslvKDncSbo0vICkK9Fw2vK-1qIdLWU9bimAHVnXyf4-WVoSoPBpo4Dg,ACYDBNhfbX0KCc71KD8lFVs2_JnRo0vcR0uk4GqkH6btZxMGY2v8akCNkjgLYfuPe1JBxN4,ACYDBNgz_vU88IuGGWoXGBIDMw2aMbmY7PZuP59sB-t1MKdG91HpSPumI12y44zJoNWByD0,ACYDBNjPpX7i2IAz5HFsOhe4kSmMJz4BqyfNFnvfKsqjHo8hDe0VbqbtTqFZBJlpIBGxL80,ACYDBNi5wEDP9TRwB3vSOXex6Kww1iL1U84QroEMXyC4c_PtEBXXTN118DIGBYBlXbAeme8,ACYDBNiaQlFj9Conlm1SCtSyK3Ir2i7WIXkuVZeMBX9p5GNKN16ViaCwksMBgNC7qQgUAYc,ACYDBNie04gQd7Jb2nRK-B2Lno6wU4CcKRwtqoaSl_RtDWL2r8J6oKLmAi7fOfgwqmDpUNY,ACYDBNhHr-rtejdiY9oCeinPKI6-x33Pu89Ag-ZwpnSaFhb_zLVjfH9X7vItddCLXf7MsyQ,ACYDBNgSQHZGgJy850nGJ9NwDbtqd0jP0d_1tT36sWwy9MEPI65IjMWciRSYP0ahyQWBec0,ACYDBNiaxUBqPHaPEnEdNLVRtq1dzOr-ZgppIma0xQXMwvoFDqakJ0ufLyKwjT5I5T92sPQ,ACYDBNg4vW8Jv60gGdNlGniyGgKYaTgGovdoIM3VkFQRrm0g3-WI7QS-gHoH4OTrzewUNTs,ACYDBNg6ueSR_xy1pFz3hRRZvLJaEQKI5vi4u6jHsZnMW8oGp312z_vWxwFXusEM_mkF32c,ACYDBNhSKZS3kel2Fj1dG8C6baLaRfmIyCjdkDyd0o9okaRPGqSBmj0kh8rPhIg3fHiKr70,ACYDBNjhHgTqJTi2AR9iN8SPUskiS2Z27MWOJ0IWsEiCKGpchH5jDe59l4__mry8dcpBwb8,ACYDBNjjyMPMy6iwvnVjH0sO4z7lpxfTtq_xLscFRUYGERToWrZ1SEBSy51miYhmdDUS3QI,ACYDBNipfVlz2NXInCsiTE2rq8E_w09xOMCvr0fDKXC0shkIHxQMmZzKuP0BRV4H_350uJA,ACYDBNjt8Lgnzot7qqB5hL8kifoyaiRS7iSEPs8V24Q-OfLwgsy7azYVYWDWQHiGRdw98pE,ACYDBNjFyV2mrm3H0NInyts6_OCa56BpYzNP5G25HwuO7ajD15yGUjMBCgDG_DQFmqDgIOE,ACYDBNhAAg__BL9R2TF_Olr6947igbixaEsBzZf-V_qe0nykyt9v3DhurOI8nnHKPPLBGps,ACYDBNiyAOxwN_aPl_pIEDCY4_ck2phvjYsagU4yOYwH1Zi83co_7QbwASxLd6-iU0w9P1o,ACYDBNg1yqDrtgABUTxtbKBkNTR8xg4p7B9peM1X58FkX3CeuPgXRmFZQ0U5i7HZCY1YQwU,ACYDBNhu_uB9DBZ2NdrkKou_RpRiLsJLfsAokZ-a6PsiMjJI5b13fQ3wvRzCKl4otGQHBNw,ACYDBNhqzbQfeYW48EztIjUTn9OkIk86CbkEy-jglRFNoUYTg4vlgefhfpUAYijq8VygM0g,ACYDBNg8x5eeV2cB91i369Hd71WKBzpBCCD8SilhNYCYlZ4AvOuFXYJ46nbkLBd_ck1ftqg,ACYDBNjN0A_nwqVPOVJyQYzaLjshbgt4Jo9ynnasSeU1yMfUWErhWc9NLOs7TDM1cAbqfCA,ACYDBNjYGFaUx9UcXLh01vOeoFx_teDU987H55qiWpZOoNMSODwWDXVEhqMcS7ROTeoc6QY,ACYDBNimSP0c058MPuMZsznqlaEiCGJ0btNSn7RrtOjueNXQ7fhUW9A_mAzUlxzSrURUDpM,ACYDBNg_T8aoanRqYa39yRTfozdxKf-OABhSeFtYA6ZLQBrBKGtZS85vMzRlzklVOZyCM9k,ACYDBNh0hfig0kcOHuIBwc_kbLi1XXYYpGKkZHtYGgqgZXycR1JeLq2l3KuEe48GmI44f6A,ACYDBNh_XlP4LF4ApjR3JE4J26H3_Ts-xBMP8hcfHvHYRXo6obeSyd6KLIfmbpu6C6oOvSg,ACYDBNgS19yaqwW1xWKulFaORZW9cZWb6K3XS4clbDQqcx0oKkH8NgBjTOqHfClI8dRLzwc,ACYDBNjyqJBjRNau6gn7fDIagUTbsGyy9XD_B60Pme8w84Bnj9zwfOMcO1-TAbAaN99T4XQ,ACYDBNgcIxhqYKbTo7H_04jkIEnGqnHLEps3kO4qIQrJELu0ipkRPjisbZK9AvX-mNCGSyI,ACYDBNhxpmNOY81WMBIBmmq0n0Xu8uhCu1TPLf5Y3YHHyzLmiuZtVTFOrgCRRKc5ciah4lo,ACYDBNjcpv0rpZXPEpn8Vn5Z4R83_roJM9hMbF5J3nI9Ncaq-CM-Cz4TQl2crp2jLh4JUbk,ACYDBNjdGCC6zr072SBSNSzGZDr0AVVEckTDedvpaVpZVVS6x2u87bxCdjl45ZfNp6hfWgU,ACYDBNiGlwHF2PbbVN2_4_1Oa2ivKQridMsmvuQaCqnhR9IfbhsONIr6knY8JqcjFsX2RXA,ACYDBNgcr37L7W9AUPP9a3igjpRvqT7KEWowDlgbkK7KhRwT5oKjfyy-ZJ6pr4kOBvbW-A0,ACYDBNi8BcAKTSeWKVwU1pGYGqv50W1ogcd6FGvWvJzE7kQ1mZeDqBJd4hznXpXZSTaUX8Y,ACYDBNi5nhbraCZXpbycC4Oo-cBdV9-2849NOyI_ZoN4_TExeYC3wc8lQq4J-7SI7kvNb3U,ACYDBNhbdlNsSyG9SBZFSdw6_E1m7h1jFZylQpt72j53ldFmcnFBuADa5akm2xuhsWxWwqg,ACYDBNiI4CaF9SqhMExl84AZaUuKZMDAUBSROxNbmdzV-aU9n_eXwUBNNousCNMLmYDncow,ACYDBNj0nbaHb4gVNkrYs1sjr6BB_cxt4_ahT7cP2gLUoFtbJe7xjgwPLvxoHfc6rpeH6qw,ACYDBNizwcb6GwNOHTYg9oZ-dJSxsDCMyM17JJESvZacr4F-cwQa2-AsQZWM8Oxy61F0HmU,ACYDBNjSdjpw81fWgkGqRB5rpQ1W1HhxpXpTA4F5WMiJo-yyj5WqtO41IHy9scUSvw2rnKA,ACYDBNjP1TMAXrBSo5tInp7QWsFCk29e5DfcTRqH-oDBO7tHoFLYMvyzRf4dDq9s9PC2APw
custom1,Project ID,DC01_090823,HL01_091523,JV01_091323,JV01_091523,AY01_091923,HL01_100223,KM01_110223,KM01_101923,YD01_092923,HL01_110323,HL01_110623,AY01_110823,HL02_092223,WO01_121123,XL01_121123,VT01_121323,HL01_121523,WO01_012624,MG01_120123,JK01_021524,JK01_021624,MG01_021624,JK01_030724_BR1,AB01_030724_BR,XS01_030724_BR,BD01_030724_BR,MW01_030724_BR,HL02_030624_BR,AY02_030624_BR,NH01_032224,MG01_030624_BR,OR01_030624_BR,JK01_030724_BR2,PP01_030724_BR,XY01_030724_BR,TN01_030724_BR,TM01_031324_BR,AD01_031024_BR,ND01_031524_BR,JC01_031824_BR,XL01_031924_BR,MA01_031924_BR,RJ01_032024_BR,JK01_032024,HG01_032224_BR,WO01_032124_BR,NH01_040224_BR,KR01_032224_BR,HN01_040224_BR,MS01_040424_BR,DC01_040424_BR,MG01_040624,MG01_040524,KM01_040524_BR1,KM01_040524_BR2,AY02_041924,AY02_043024,RS01_043024,AY01_043024,AY01_051024_BR,WO01_060424,QZ01_061024_BR,MG01_061424,AY01_062024,HG01_062124,MG01_062524,AS01_072624_BR,WO01_073124_2,WO01_073124_1,VT01_080224_BR,YD01_080824,HG01_081324,WO01_082024,RS01_090524,IB01_091224,NG01_091924_BR,OF01_092624_BR,YW02_101124,AY01_100824,WO01_101124_1,WO01_101124_4,WO01_101124_3,WO01_101124_2,MG01_091124,OR01_101524,OR01_102324,OR01_102824,WO01_110424,ND01_110724,YW02_110824,XZ01_111124,AY02_111424,WO01_110624,CP01_120424_BR,DG01_121924,DG01_121724,RJ01_122024_BR,DG01_122324,OR01_011325,OR01_011625,ND01_011625,HN01_012425,SP01_020525
custom2,Reponsible Person,XZ,XZ,XZ,JW,XZ,XZ,XZ,XZ,JW,XZ,JW,XZ,JW,XZ,XZ,XZ,XZ,XZ,JW,JW,XZ,XZ,-,-,-,-,-,-,-,XZ,-,-,-,-,-,-,-,-,-,-,-,-,-,JW,-,-,-,-,-,-,-,XZ,JW,-,-,XZ,XZ,JW,XZ,-,XZ,-,XZ,XZ,JW,JW,-,XZ,XZ,-,JW,JW,XZ,XZ,XZ,-,-,XZ,JW,XZ,XZ,XZ,XZ,XZ,XZ,JW,XZ,XZ,XZ,JW,XZ,JW,XZ,-,XZ,JW,-,JW,XZ,XZ,XZ,XZ,XZ
custom3,Complete status,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,completed,-,-,-,-,-,-,-,completed,-,-,-,-,-,-,-,-,-,-,-,-,-,completed,-,-,-,-,-,-,-,completed,completed,-,-,completed,completed,-,completed,-,completed,-,-,completed,completed,completed,-,completed,completed,-,-,completed,completed,-,completed,-,-,completed,completed,completed,completed,completed,completed,completed,completed,completed,-,completed,-,-,completed,completed,completed,-,completed,completed,-,-,completed,completed,completed,-,completed
custom4,Bill,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,-,Yes,-,-,Yes,Yes,Yes,Yes,Yes,Yes,-,-,Yes,Yes,Yes,-,-
custom5,Paid,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,Yes,Yes,Yes,-,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,Yes,Yes,-,Yes,Yes,-,Yes,-,-,Yes,Yes,Yes,Yes,Yes,Yes,-,-,-,-,Yes,-,-
1bee076f,Authoship Disclosure Agreement,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications,I have read the authorship disclosure and will acknowledge the CAIPP Bioinformatics Modeling Core in publications
644d300e,Request Date,2023-09-08,2023-09-15,2023-09-22,2023-09-15,2023-09-19,2023-10-02,2023-11-02,2023-10-19,2023-11-02,2023-11-03,2023-11-06,2023-11-08,2023-11-30,2023-12-11,2023-12-11,2023-12-13,2023-12-15,2024-01-26,2023-12-01,2024-02-15,2024-02-16,2024-02-16,2024-03-07,2024-03-07,2024-03-07,2024-03-07,2024-03-07,2024-03-06,2024-03-06,2024-02-23,2024-03-06,2024-03-06,2024-03-07,2024-03-07,2024-03-07,2024-03-07,2024-03-13,2024-03-10,2024-03-15,2024-03-18,2024-03-19,2024-03-19,2024-03-20,2024-03-20,2024-03-22,2024-03-21,2024-04-02,2024-03-22,2024-04-01,2024-04-04,2024-04-04,2024-04-05,2024-04-05,2024-04-05,2024-04-05,2024-04-19,2024-04-30,2024-04-30,2024-05-06,2024-05-10,2024-06-04,2024-06-10,2024-06-14,2024-06-20,2024-06-21,2024-06-25,2024-07-26,2024-07-31,2024-07-31,2024-08-02,2024-08-08,2024-08-13,2024-08-20,2024-09-05,2024-09-12,2024-09-19,2024-09-26,2024-10-11,2024-10-08,2024-10-11,2024-10-11,2024-10-11,2024-10-11,2024-09-11,2024-10-15,2024-10-23,2024-10-28,2024-10-29,2024-11-07,2024-11-08,2024-11-09,2024-11-13,2024-11-06,2024-12-04,2024-12-17,2024-12-17,2024-12-20,2024-12-23,2025-01-13,2025-01-16,2025-01-16,2025-01-24,2025-02-05
0b02c22e,If it is an existing project,No,No,No,No,No,HL01_091523,KM01_101923,No,No,HL01_091523,No,AY01_091923,"sgk1, Lee lab",No,no,HL01_110323,HL01_091523,No,No,No,No,MC01_120123,No,-,NO,Biochemistry and Molecular Biology,No,No,No,No,No,No,JK01_030724_BR1,No,No,No,NO,No,NO,No,No,-,No,No,No,No,No,No,No,no,DC01_090823,MC01_120123,MC01_120123,No,No,No,AY02_041924,No,No,No,WO01_012624,No,No,No,No,No,No,No,No,No,No,No,WO01_073124_2,RS01_043024,No,No,No,No,No,No,No,No,No,No,No,No,No,No,NO,No,NO,No,WO01_101124_1,No,No,No,No,No,No,No,No,No,No
60e380b9,PI Name,Diana Cruz,Hungwen Lin	,John Vanchiere,John Vanchiere,Andrew Yurochko,Hungwen Lin	,Kevin Murnane,Kevin Murnane,Yufeng Dong,Hungwen Lin,Hungwen Lin,Andrew Yurochko,Huichao Lee,Wayne Orr,Xiaohong Lu,Hungwen Lin,Hungwen Lin,Wayne Orr,Monica Cartelle Gestal,Jeremy Kamil,Jeremy Kamil,Monica Cartelle Gestal,Jeremy Kamil,Arrigo De Benedetti,Xinggui Shen,Baojin Ding,Matthew Woolard,Huichao Lee,Arif Yurdagul,Norman Harris,Monica Cartelle Gestal,Oren Rom,Jeremy Kamil,Paula Polk,Xiuping Yu,Taichiro Nonaka,Tarek Magdy Mohamed,Ana-Maria Dragoi,Nirav Dhanesha,Jason Comer,Xiaohong Lu,Mabuak Alfaidi,Rohit K Jangra,Jeremy Kamil,Hongyan Guo,Wayne Orr,Norman R. Harris,Krista Rodgers,Hyung Nam,Martin Sapp,Diana Cruz,Monica Cartelle Gestal,Monica Cartelle Gestal,Kevin Murnane,Kevin Murnane,Arif Yurdagul,Arif Yurdagul,Rona Scott,Andrew Yurochko,Andrew Yurochko,Wayne Orr,Quanguang Zhang,Monica Cartelle Gestal,Andrew Yurochko,Hongyan Guo,Monica Cartelle-Gestal,Armando Salinas,Wayne Orr,Wayne Orr,Vesna Tesic,Yufeng Dong,Hongyan Guo,Wayne Orr,Rona Scott,Iqbal Bhuiyan,Nicholas E. Goeders,Omar Franco,Yuping Wang,Andrew Yurochko,Wayne Orr,Wayne Orr,Wayne Orr,Wayne Orr,Monica Cartelle-Gestal,Oren Rom,Oren Rom,Oren Rom,Wayne Orr,Nirav Dhanesha,Yuping Wang,Xuemei Zong,Arif Yurdagul,Wayne Orr,Christopher B. Pattillo,David Gross,David Gross,Rohit Jangra,David Gross,Oren Rom,Oren Rom,Nirav Dhanesha,Hyung Nam,Sadiya Parveen-Nesson
000f4279,Funding Source ,LaSPACE,AHA TPA,5496001037,Dr V IDC,NIH,113-1492500-10001-35200-149251192A,"Pharmacology, Toxicology, & Neuroscience Departmental seed fund","Pharmacology, Toxicology & Neuroscience - Department Seed",NIH,1492500 113 10001 40001 5492501040,NIH NINDS RF1NS132291,NIH,NIH and AHA,NIH R01 Grant,NASA,AHA TPA ,AHA TPA,113-1001-1102800-20200-110281205A,Cobre,"[""Chancellor's Aim High Award (Intramural)""]",NIH,COBRE,Intramural grant and NIH grant,CCRI6,113 1102800 10001 90100 5102801017,110151180A,1102500 113 10001 20200 110251255A,American Heart Association,110351265A,Intraumal Aiming high grant,NIGMS CAIPP COBRE,Pathology Seed,Intramural grant and NIH grant,account ,indirect account,Anatomy seed package,110281507A,Start-up Physiology,NIH/NHLBI,Seed Package ,CEAR,American Heart Association,Lab Seed Funds,"[""Chancellor's Aim High (Intramural) ""]",NIH,NIH Grant,PI: Hypertension Grant ,NINDS,CCDS intramural,NIH/NIAID,NIH ,Cobre,COBRE,Pharmacology Department.  Dr. Murnane's Grants,Pharmacology Department.  Dr. Murnane's Grants,R01,NIH R01,Indirect Cost account,113 1102500 10001 35200 110251248A,1102500 113 10001 35200 110251251A,Grant,seed package,Seed package,OHSU PPG, COBRE lead project,COBRE,Internal funding,NIH R01 Grant HL133497,NIH R01 Grant HL133497,Internal,NIH,COBRE,RO1,Internal,Neurology Research Fund ,NIH,Internal,Department IDC,PPG Grant,R01,R01,R01,R01,Internal,Pathology seed,CCDS seed ,CCDS seed funds,R01,R01,NIH,Seed Package,R01HL167758,R01,Internal,D.S. Gross Chancellor's Bridge Account,D.S. Gross Chancellor's Bridge Account,CAIPP CoBRE,"[""Chancellor's Bridge Account""]",Cardiometabolism program,Cardiometabolism program,Aim High Award,CCDS,Seed Package
5738e880,Account number and billing contact person,"110351281A,Wes Brantley,318-675-6010","113-1492500-10001-35200-149251192A,Jessica Cote,318-675-8299","5496001037,Matthew Vitacca,(660) 238-1828","5496001037,Matthew Vitacca,660 238-1828","113 1102500 10001 35200 110251248A, Dominique Williams,(318)-675-5750","113-1492500-10001-35200-149251192A,Jessica Cote,318-675-8299","5103001063, Darrell Cooley, 318-675-7853","5103001063, Darrell Cooley, 318-675-7853","149451056A,Monica Henderson,675-6178","113-1492500-10001-35200-149251192A,Jessica Cote,318-675-8299","1492500 113 10001 20200 149251197A,Jessica Cote,318-675-8299","113 1102500 10001 35200 110251248A, Dominique Williams,(318)-675-5750","149251190A, Jessica Cote, 5-8299","113101110280020200110281205A,Tremendous Carroll,(318)-675â€“5860","5103001072, Darell Cooley, (318) 675-7853","113-1492500-10001-35200-149251192A, Jessica Cote, 318-675-8299","149251158A, Jessica Cote, 318-675-8299","110281205A,Carroll Tremendous,3186755860","110251235A, Dominique Williams, 318-675-5750","113-1102500-10001-35200-110251261A,Dominique Williams, 318-675-5750","1102500-113-10001-20200-110251254A,Dominique Williams, 318-675-5750","110251235A, Dominique Williams, 318-675-5750","113-1102500-10001-35200-110251261A,Dominique Williams,318-675-5750","1101500 113 10001 40170 5101501085, Dede Plette, 318-675-5959","113 1102800 10001 90100 5102801017,Tremendous Carroll,318-675-5860","110151180A, Dede Plette, 318-675-5959","1102500 113 10001 20200 110251255A,Dominique Williams,318-675-5750","149251201A, Xiaohui Ma, (318)-675-5682","110351265A,Wes Brantley,(318)-675-6010","113-1103500-10001-35200-110351290a, Wes Brantley, 3186756010","110251235A, Dominique Williams,(318)-675-5750","5102801043, Mary Hartman, (318)-675-5861","1102500-113-10001-20200-110251254A,Dominique Williams,318-675-5750","113 110400 10001 4001 5104005003, Paula Polk, (318)-675-4939","5101501073, Dede P. Plette, 318-675-5959","5101001052, Rachel Webster, (318)-675-5326","110281507A, Mary Lyle, 3186755861","1103500 113 10001 90100 5103501067, Wes Brantley,(318)-675-6010","110281232A,Dominique Williams,318-675-5750","5102501190,Dominique C. Williams, 318-675-5750","5103001072,Darell Cooley,(318)-675-7853","149212015A, Tisha Samhan, (318)-675-7055","5102501080,Dominique C. Williams, 318-675-5750","113-1102500-10001-35200-110251261A, Dominique Williams, 318-675-5750","110251252A,Dominique C. Williams, 318-675-5750","113 1102800 10001 20200 110281205A,Mary Hartman, (318)-675-5861","113-1103500-10001-35200-110351280A, Thomas Brantley,(318)-675-6010","110101121A,Rachel Webster,(318)-675-5326","110301215A,Darrell Cooley,318-675-7853","110251236A, Dominique C. Williams, 318-675-5750","110351253A, Wes Brantley, (318)-675-6010","110251235A, Dominique Williams,(318)-675-5750","110251235A, Dominique Williams,(318)-675-5750","110301212A,Darrell Cooley,675-7853","110301208A, Darrell Cooley, 675-7853","110351288A, Wes Brantley, (318)-675-6010","110351288A, Wes Brantley, (318)-675-6010","5102501042, Dominique Williams, 5-5750","113 1102500 10001 35200 110251248A, Dominique Williams,(318)-675-5750","1102500 113 10001 35200 110251251A, Dominique Williams, (318)-675-5750","110281205A, Tremendous Carroll, 318-675-5860","1492500-113-13000-40700-5492503002, Vanessa Davis, (318) 675-7039",1226A ,"110251248A,Dominique Williams,(318)-675-5750","110251267A, Ashely Abrams, (318) 675-5750","113 1102500 10001 35200, Monica Cartelle-Gestal, 706-461-3934 ","5103001065,Darell Cooley,318-675-7853","113 1102800 10001 20200 110281205A, Tremendous Carroll, 318-675-5860","113 1102800 10001 20200 110281205A, Tremendous Carroll, 318-675-5860","1492500 113 13000 40700 5492503001, Vanessa Davis, (318) - 675 - 4888","149451056A,Monica Herderson,675-6178","113-1102500-10001-20200-110251267A, Dominique Williams, 5-5750","113 1102800 10001 20200 110281205A,Tremendous Carroll, 318-675-5860","5102501042, Dominique Williams, 5-5750","5492503004, David Vanessa, 318-675-4888","111-1103000-10001-10105, Darrell Cooley, (318)-675-7853","5101501080, Dede Plette, 318-675-5959","5493301013, Tisha Samhan, 318-675-7055","110251248A,Ashley Abrams,(318) 675-5750","113 1102800 10001 20200 110281205A, Donna Brice, (318)-675-7659","113 1102800 10001 20200 1102815110A, Donna Brice, (318)-675-7659","113 1102800 10001 20200 110281205A, Donna Brice, (318)-675-7659","113 1102800 10001 20200 110281205A, Donna Brice, (318)-675-7659","113 1102500 10001 35200, Dominique Williams, (318)-675-5750","113 1102800 10001 55200 110281212A,Mary Hartman, 318-675-5861","113 1102800 10001 55200 110281212A,Mary Hartman, 318-675-5861","113 1102800 10001 55200 110281212A, Mary Hartman, 318.675.5861","113 1102800 10001 20200 110281205A, Donna Brice, (318)-675-7659",Donna Brice 57659,"149331071A, Yuping Wang, 318-675-5673","113-10001-40350-1492500-5492501044, Vanessa Davis, 3186754888","110351288A,Lauren Draper, x-6012","113 1102800 10001 20200 110281205A, Donna Brice, (318)-675-7659","110351306A, Megan Watts, (318) - 675 - 6010","1101500 5101501088, Dominique Williams, x56618","1101500 5101501088, Dominque Williams, x56618","113-1102500-10001-20200-110251240A, Ashley Abrams, (318) 675-5750","5101501088, Dominique Williams, 5-6618","110281519A,Mary Hartman,318-675-5861","110281519A,Mary Hartman,318-675-5861","110281526A,Donna Brice, (318)-675-7659",Tanya Patterson,"5102501191, Ashley Abrams, (318)-675-5750"
000f425b,Project title,Effects of gamma-radiation on brown adipose tissue,3xTg-AD treatment trials,JC Virus Infection,Purified JC & BK Polyomaviruses ,HCMV vs Mock at 5 time points experiment,VT analysis M vs F,Acute Psychedelic pathway analysis,Psychedelic HTR Sequencing,Identification of distinct molecular signature of human bone marrow stromal cells,VT GNX vs vehicle,Methyl seq_Lin PRMTs,Bioinformatics Analysis of HCMV Infection of Monocytes,kinase regulation in the brain,Role of EphA2 in VSMCs,Space brain,3xTg-AD treatment trials,3xTg-AD treatment trials,hVSMC-LN vs FN Matrix,Single cell analysis of the lung responses to Bordetella spp. infection,Sequencing HCMV Genomes,HCMV UL148 mass spectrometry,scRNA sequencing lungs after Bordetella bronchiseptica infection,Biorender,Identification of gene targets for effective cisplatin-based treatment of prostate cance,BioRender,BioRender,BioRender,BioRender,BioRender,Methamphetamine induced retinopathy,BioRender,BioRender,BioRender,BioRender,BioRender,BioRender,BioRender,BioRender,Mechanisms for Deep Vein thrombosis following Stroke,BioRender,Long COVID ,BioRender,BioRender,HCMV BAC Genome Assembly,The contribution of RIPK3 to HSE,BioRender,BioRender ,BioRender,BioRender,Biorender,BioRender,scRNAseq lungs,Connectome,BioRender,BioRender,ODC-Mediated MYOCD Suppression in SMC Dedifferentiation,ODC-Mediated MYOCD Suppression in SMC Dedifferentiation,Copositivity of EBV and HPV in oropharyngeal squamous cell carcinoma,Investigating the Role of the JAK/STAT Pathway in HCMV Latency,BioRender,hVSMC contractile siNDRG2,BioRender,Transcriptomic changes associated with endometriosis,Phosphoproteomic Profiling of Monocytes During HCMV Infection,Brain scRNA-seq,BB0870 BB0931 RB50 Alignment,BioRender,30-1041346239,30-1041327814,BioRender,Radiation effect on bone tissue,HSV sequencing ,30-1041346239_NGS,Copositivity of EBV and HPV in oropharyngeal squamous cell carcinoma,Cognitive impairment in high fat diet-induced mice,BioRender,BioRender,Ins-PC project,HCMV Variant Analysis,WO01_073124_3_30-1078251968,30-1078242059,30-1078234943,30-1078207427,TCR in bulk RNAseq data generated in the lab,Primary Hyperoxaluria subtyping,Role of macrophage SHMT2 in atherosclerosis,Hepatic SHMT2 in atherosclerosis,TG 30-1078259709,Stroke Metabolomics,Spatiotemporal transcriptomics the maternal-fetal interface in COVID placenta,Xuemei Zong-CBS,Yurdagul Spatial Transcripomics,30-1078251968 pathway analysis,BioRender,Extragenic Suppressor Identification,Hi-C,BioRender,Mediator Tail Module 3D Structure,MASH-Atheroscerosis model paper,MASH-Atherosclerosis model ,RNA-seq,Pathway Analysis for Metabolomics ,SigA Bulk RNA sequencing
39a4f614,Project Description,Mouse controls vs. mouse lacking glucocorticoid receptors in brown adipose tissue exposed to gamma-radiation and no exposed. RNA was isolated using QuantaBio (https://www.quantabio.com/product/extracta-plus-rna/). ,"We treat 3xTg-Ad mice with different treatments from different projects, which some involve young, old, male and female. We extract brain and isolate RNA from hippocampus and cortex.","JC Virus (3 subtypes - WT, Mad-1, S269F) infection(s) of HEK293TT Cells with mock infection",Three JC virus strains and a wildtype BK virus cultured in 293TT cells & purified by ultracentrifugation,"HCMV and Mock infected at 4h, 24h, 2wk, 4wk, 6wk",mouse brain,"mouse brain tissue, swiss-webster mice, acute psychedelic drug administration","Male Swiss-Webster mice, brain tissue (Prefrontal cortex & Striatium), TRIzol RNA extraction, Treatment (Saline, Psilocybin, R(-)2, 5-dimethoxy-4-iodoamphetamine[R(-)DOI], 4-hydroxy-diethyltryptamine [4-HO-DET])",human bone marrow stromal cells,"mouse brain regions, from 3xTG animals treated with vehicle or GNX","Mouse brain tisse (C57, 3xTgs and PRMT8KO). Qiagen extraction kit",Human Monocytes were infected with HCMV and time course of infection was performed,-,"primary VSMCs were transfected with an siRNA against EphA2 and cultured overnight in 1%FBS. I performed the experiment in triplicate, meaning I have 3 mock samples and 3 siEphA2 samples.",Effects of space radiation on mouse brain,"We treat 3xTg-Ad mice with different treatments from different projects, which some involve young, old, male and female. We extract brain and isolate RNA from hippocampus and cortex.\n","We treat 3xTg-Ad mice with different treatments from different projects, which some involve young, old, male and female. We extract brain and isolate RNA from hippocampus and cortex.","hVSMCs were plated on differing extracellular matrices, either laminin (LN) or fibronectin (FN) for 72 hours in serum-free media, followed by RNA isolation.","For this project we have used two different mouse strains; Balb/c (wild type mouse) and GATA-1 (which are eosinophil deficient mice). These two strains were infected with RB50 (wild type strain of Bordetella bronchiseptica) or a BBmut strain. At day 7 post-infection lungs were collected, labeled with CITY-Seq and process in the Core facilities to obtain single cell RNA sequencing",Cytomegalovirus BACs were harvested from E. coli (midiprep) and sent off for nanopore sequencing. The raw reads (fastq format) needed to be assembled. ,HCMV strain TB40E or TB40E_148stop was infected into Human Foreskin Fibroblasts (HFFTs) at MOI of 2 and collected 72 hours post-infection.,"We are using mouse lungs at day 7 post-infection with the wild type strain of Bordetella bronchiseptica, RB50, or a mutant strain, BBmut, that cannot suppress host immune responses. Using single cell suspensions we are aiming to identify the changes in the signaling pathways in macrophages, alveolar macrophages and T cells that lead to the differences in the immune response previously  observed.",5 biorender licenses for the year,-,-,-,-,-,Renew Biorender,Isolated retina from Wistar rats after methamphetamine administration,-,-,-,-,-,-,-,-,-,-,Mouse model,"Cardiovascular Research utilizing Western blot, immunoprecipitation, and immunostaining assays for antibody specificity and cross-reactivity between human and mouse tissues.",-,HCMV BACs from GS1783 E. coli isolated via MidiPrep. Illumina sequencing carried out by MiGS (now known as SeqCoast),-,Biorender,-,BioRender License ,-,-,BioRender License,Lungs of infected mice,"scRNA seq lungs. Total connectome of RB50, BBmut and the differential connector showing the genes that are differentially expressed between Balb/c mice infected with RB50 or BBmut.",Renewing BioRender License ,Renewing BioRender License ,Transfected Human vSMCs,Transfected Human vSMCs	,"Human tumor samples, existing Single Cell RNA-seq dataset in GEO","The project aims to identify interferon stimulated genes (ISGs) downstream of the JAK/STAT pathway, induced during HCMV infection, which helps to drive virus latency. The experiment is performed in THP1 cells.\n\nThe experimental groups include:\nMock (THP1 cells only)\nIFN-Beta (THP1 cells treated with IFN-B)\nWT THP1 cells infected with HCMV, harvested at 1, 3 and 5 days post infection\ndelta IFNAR2 THP1 cells infected with HCMV, harvested at 1, 3 and 5 days post infection\ndelta STAT1 THP1 cells infected with HCMV, harvested at 1, 3 and 5 days post infection\n\nThe cells were harvested and RNA isolated with the traditional phenol-chloroform technique. RNA was then sent to the sequencing core facility for RNA-seq.",-,have 3x mock samples and 3x siNDRG2 samples. Human VSMCs. Standard RNA isolation and bulk RNA seq.,-,These are published RNA datasets from clinical samples of healthy women and women suffering endometriosis or other type of reproductive disorder.,"Isolated human primary monocytes, uninfected (mock) and infected (HCMV), over time",-,Mutant Bacterial Genome Alignment,-,"Human aortic endothelial cells were treated with Nck1 siRNA and AFT3 siRNA, subjected to 18 hours of shear stress, and subsequently collected in 200ul of Trizol.","Mouse Lung endothelial cells were isolated from  Nck1 KO and cntrol mice, subjected to 18 hours of shear stress, and subsequently collected in TRIzol for further analysis.",-,mouse spine,Sequencing two hsv strains,-,"Human tumor samples, existing Bulk RNA-seq controlled dataset in GEO PRJNA842485",Astrocyte and microglia cells isolated from mouse brains,-,-,Placental-MSCs,I recently sequenced a strain of HCMV (TB40E) from Plasmidsaurus. The company used the nanopore sequencing platform. I have my reads but I need to assemble the genome sequence from the reads.,Human aortic ECs subjected to either OSS or static conditions and treated with TUDCA or control,Mouse Liver cells isolated from controle and Nck1 Ko mice,Mouse lung ECs treated with a5/av si RNA and with either GFP or CRE,Human aortic ECs treated either with control or with a5 av si RNA,-,Serum samples from donor patients,"We have 3 groups [Bone marrow derived macrophages (BMDMs) treated with BSA, Palmitate (PA), Lipopolysacride (LPS)] from each sample. We have 4 samples of wild type (WT) mice BMDMs treated with BSA, PA, LPS and 4 samples of Knockout (KO) mice BMDMs treated with BSA, PA, LPS .                                                                                                                                                               We request analysis from BMDM samples, including Principal-component analysis (PCA) of gene expression data, volcano plot, heat map of differential gene expression (DEGs), pathways enriched in the up- or down-regulated DEGs KEGG pathway using nominal p value.","Apoe KO mice on a 12 week WD were used to model atherosclerosis, with or without the deletion of hepatic SHMT2. Livers and plasma were isolated and metabolites were quantified.",TG ganglion from control and irradiated mice,-,"Placenta, FFPE, 10X Visium",Rat and mouse Brain ,-,Human aortic ECs subjected to either OSS or static conditions and treated with TUDCA or control,-,DNA sequencing of genomic DNA samples isolated from 3 budding yeast strains,Generate Hi-C Contact Maps - from FASTQ files of budding yeast +/- heat shock,-,Alphafold modeling of 3D protein structures,"In the present study, we utilized both male and female atheroprone mice subjected to different dietary regimens, applying a multiomics approach that combines metabolomics, lipidomics, and transcriptomics with histopathological and biochemical analyses in the liver, atherosclerotic tissue and plasma.","Ldlr KO mice were fed with SD, WD, mCDHFD and mMASHD for 24 weeks and analyzed for MASH and atherosclerosis.",Cells ,Pathway Analysis for Metabolomics ,"RNA isolated from Mycobacterium tuberculosis, followed by mRNA sequencing"
7a805a0c,Service Type,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,DNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,DNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,DNA-Seq analysis,Proteomics analysis,RNA-Seq analysis,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,RNA-Seq analysis,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,DNA-Seq analysis,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,BioRender license,RNA-Seq analysis,RNA-Seq analysis,BioRender license,BioRender license,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,BioRender license,RNA-Seq analysis,BioRender license,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,DNA-Seq analysis,BioRender license,RNA-Seq analysis,RNA-Seq analysis,BioRender license,RNA-Seq analysis,DNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,BioRender license,BioRender license,RNA-Seq analysis,DNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,Metabolomic analysis,RNA-Seq analysis,Metabolomic analysis,RNA-Seq analysis,Metabolomic analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,RNA-Seq analysis,BioRender license,DNA-Seq analysis,DNA-Seq analysis,BioRender license,Alphafold modeling ,Metabolomic analysis,Metabolomic analysis,RNA-Seq analysis,Metabolomic analysis,RNA-Seq analysis
27d5e97c,RNA Analysis Service Type,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,-,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,"Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customerized Integration, Annotation, and Comparisons","RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","New genome annotation/GTF file (species/strain), Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customerized Integration, Annotation, and Comparisons","RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customerized Integration, Annotation, and Comparisons",-,-,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,-,-,-,-,-,-,RNA-seq DEG Analysis,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",Connectome,-,-,RNA-seq DEG Analysis,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)","Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customized Integration, Annotation, and Comparisons",RNA-seq DEG Analysis,-,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,RNA-seq DEG Analysis,RNA-seq DEG Analysis,"New genome annotation/GTF file (species/strain), Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customized Integration, Annotation, and Comparisons",-,-,RNA-seq DEG Analysis,RNA-seq DEG Analysis,-,"Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customized Integration, Annotation, and Comparisons",-,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,RNA-seq DEG Analysis,-,-,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,"RNA-seq DEG Analysis,Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",RNA-seq DEG Analysis,RNA-seq DEG Analysis,RNA-seq DEG Analysis,TRUST4,-,"RNA-seq DEG Analysis,Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,RNA-seq DEG Analysis,-,"Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser, Single Cell Seq: ADVANCED Analysis: Customized Integration, Annotation, and Comparisons",RNA-seq DEG Analysis,"Single Cell Seq: alignment, matrix (Cell Ranger/SpaceRanger) for Loupe Browser","Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,-,-,-,-,-,-,"RNA-seq DEG Analysis, Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,RNA-seq DEG Analysis
4ba96406,DNA Analysis Service Type,-,-,-,Variant Calling Analysis,-,-,-,-,-,-,DNA Methylation-Seq,-,-,-,-,-,-,-,-,Variant Calling Analysis,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,Variant Calling Analysis,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,"Whole Genome-Seq, Variant Calling Analysis, Customized Consultation",-,-,-,-,-,Variant Calling Analysis,-,-,-,-,-,-,Variant Calling Analysis,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,Variant Calling Analysis,"New genome annotation/GTF file (species/strain), 3C, 4C, Hi-C Seq",-,-,-,-,-,-,-
762e425d,Protein Analysis Service Type,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,"Pathway Analysis (ClusterProfiler and/or 3PodR, etc.)",-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-
4cf3ecf1,Metabolite Analysis Service Type,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,MetaboAnalyst (Metabolite Pathway Analysis),-,MetaboAnalyst (Metabolite Pathway Analysis),-,MetaboAnalyst (Metabolite Pathway Analysis),-,-,-,-,-,-,-,-,-,"Customized Consultation, MetaboAnalyst (Metabolite Pathway Analysis)","Customized Consultation, MetaboAnalyst (Metabolite Pathway Analysis)",-,MetaboAnalyst (Metabolite Pathway Analysis),-
6b210e49,Organism and Species,Mouse,Mouse,"Viruses, JC Virus",Viruses,Human,Mouse,Mouse,Mouse,Human,Mouse,mouse,"Viruses, HCMV",Mouse,Human,Mouse,Mouse,Mouse,Human,"Mouse, Bordetella bronchiseptica",Viruses,Human,Mouse,-,-,-,-,-,-,-,Rat (Rattus norvegicus),-,-,-,-,-,-,-,-,-,-,-,-,-,"Viruses, human cytomegalovirus (human herpesvirus-5)",-,-,-,-,-,-,-,-,-,-,-,Human,Human,"Human, Viruses, Epstein-Barr virus and Human Papillomavirus 16","Human, Viruses",-,Human,-,Human,-,Mouse,Bordetella bronchiseptica,-,Human,Mouse,-,Mouse,Viruses,Human,"Human, Viruses",Mouse,-,-,Human,Viruses,Human,Mouse,Mouse,Human,Mouse,Human,Mouse,Mouse,Mouse,Mouse,Human,"Mouse, Rat",Human,Human,-,Yeast,-,-,-,Mouse,Mouse,Human,Mouse,Bacteria: Mtb H37Rv
6b6c2a11,Data Type,Fastq RCF Genomics Core,Raw Counts,Fastq RCF Genomics Core,Variant Calling File,Raw Counts,Raw Counts,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Raw Counts,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Raw Counts,Fastq from Outside vendor,Differential enrichment/expression Table,Raw Counts,Raw Counts,Single Cell Counts Matrix (Cell/Space Ranger Matrix),Fastq from Outside vendor,Differential enrichment/expression Table,Differential enrichment/expression Table,-,-,-,-,-,-,-,Fastq RCF Genomics Core,-,-,-,-,-,-,-,-,-,-,-,-,-,"I have also included the variant calling analysis ran by MiGS, if it could be of any help.",-,-,-,-,-,-,-,-,-,-,-,Fastq RCF Genomics Core,-,GEO data Series GSE182227,Fastq RCF Genomics Core,-,Differential enrichment/expression Table,-,Raw Counts,-,Fastq RCF Genomics Core,Fastq from Outside vendor,-,Fastq from Outside vendor,Fastq from Outside vendor,-,Single Cell Counts Matrix (Cell/Space Ranger Matrix),Fastq from Outside vendor,Differential enrichment/expression Table,Fastq from Outside vendor,Raw Counts,-,-,Fastq RCF Genomics Core,Fastq from Outside vendor,Fastq from Outside vendor,Fastq from Outside vendor,Fastq from Outside vendor,Fastq from Outside vendor,Fastq RCF Genomics Core,Metabolon Processed Data,Raw Counts,Differential enrichment/expression Table,Fastq from Outside vendor,Fold change,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Fastq RCF Genomics Core,Differential enrichment/expression Table,-,Fastq from Outside vendor,-,-,-,Differential enrichment/expression Table,Normalized Counts,Fastq from Outside vendor,Differential enrichment/expression Table,Fastq from Outside vendor
793de7c5,Library Preparation,-,-,-,-,-,-,-,-,-,-,-,-,-,-,Unstranded Library,-,-,-,-,Single-end sequencing,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,Stranded Library,-,Unstranded Library,Unstranded Library,-,-,Paired-end sequencing,Unstranded Library,Paired-end sequencing,-,-,-,-,-,PolyA depleted Library (mRNA-Seq),PolyA depleted Library (mRNA-Seq),PolyA depleted Library (mRNA-Seq),PolyA depleted Library (mRNA-Seq),-,-,-,-,PolyA depleted Library (mRNA-Seq),-,Paired-end sequencing,-,-,-,-,Paired-end sequencing,-,-,-,-,-,PolyA depleted Library (mRNA-Seq),-,PolyA depleted Library (mRNA-Seq)
06c7f244,Expected sample# ,12,30,15,4,30,37,7,30,5,72,64,30,24,32,20,37,40,6,4,2,3,3,3,1,1,1,4,1,1,16,5,1,2,1,2,4,1,1,1,1,5,1,6,3,1,5,1,5,3,5,2,5,-,1,1,18,3,16,33,6,6,1,25,28,4,2,1,17,10,1,4,2,3,133,35,1,1,16,2,16,8,8,7,17,16,24,4,6,1,12,18,20,1,1,3,3,1,1,12,12,18,2,15
556945a8,Please list all comparisons,"Controls (Flox) vs. KO,Rad-Flox vs. Rad-KO,Flox vs. Rad-Flox,KO vs. Rad-KO","CC_OFSCvsCC_OFEC,CC_OFSCvsCC_OFDC,CC_OFSCvsCC_OFCSC,CC_OFECvsCC_OFCEC","WT vs Mock,Mad-1 vs Mock,S269F vs Mock,S269F vs Mad-1,S269F vs WT",-,"HCMV4hvsMock4h,HCMV24hvsMock24h,HCMV2wkvsMock2wk,HCMV4wkvsMock4wk,HCMV6wkvsMock6wk,HCMVvsMock","VT_OMCCvsVT_OFCC, VT_YMCCvsVT_YFCC, VT_OMCHvsVT_OFCH, VT_YMCHvsVT_YFCH, VT_OMCCvsVT_YFCC, VT_OMCHvsVT_YFCH","Saline prefrontal cortex (PFC) vs psilocybin PFC, Saline striatum (STR) vs psilocybin STR, Saline PFC vs DOI PFC, Saline PFC vs 4HO PFC, DOI PFC vs psilocybin PFC, DOI PFC vs 4HO PFC, 4HO PFC vs psilocybin PFC","Saline prefrontal cortex (PFC) vs psilocybin PFC, Saline striatum (STR) vs psilocybin STR, Saline PFC vs DOI PFC, Saline PFC vs 4HO PFC, DOI PFC vs psilocybin PFC, DOI PFC vs 4HO PFC, 4HO PFC vs psilocybin PFC  ","14M23, L8M20, 23M31, L11M37, L32F58","VT_YFTC vs VT_YFCC, VT_OFCC vs VT_YFCC, VT_OFTC vs VT_OFCC, VT_OFTC vs VT_YFTC, VT_YFTH vs VT_YFCH, VT_OFCH vs VT_YFCH, VT_OFTH vs VT_OFCH, VT_OFTH vs VT_YFTH, VT_YMTC vs VT_YMCC, VT_OMCC vs VT_YMCC, VT_OMTC vs VT_OMCC, VT_OMTC vs VT_YMTC, VT_YMTH vs VT_YMCH, VT_OMCH vs VT_YMCH, VT_OMTH vs VT_OMCH, VT_OMTH vs VT_YMTH",-,time vs infection vs mock,to be determined,siEphA2 vs mock,Radiation 1 (high and low dose) vs control; Radiation 2(high and low dose) vs control,"VT_OFCC vs VT_YFCC, VT_OFCH vs VT_YFCH, VT_OMCC vs VT_YMCC, VT_OMCH vs VT_YMCH","OFCC vs YFCC, OFCH vs OFCH, YMCC vs YFCC, YMCH vs YFCH, OMCC vs OFCC, OMCH vs OFCH, OFTPC vs OFCC, OFTPH vs OFCH, YFTC vs YFCC, OFTC vs OFCC, OFTC vs YFTC, YFTH vs YFCH, OFTH vs OFCH, OFTH vs YFTH",LN vs FN,We are still working on how to better perform the analysis. Sorry I can provide more details at this point,-,"Mock vs TB40E, TB40E vs TB40E_148stop","macrophages (RB50 vs BBmut); alveolar macrophages (RB50 vs BBmut), and T cells (RB50 vs BBmut).","Anthony.domma@lsuhs.edu, Lauren.Henderson@lsuhs.edu, jeffery.nurdin@lsuhs.edu
",damilola.olatunde@lsuhs.edu,xinggui.shen@lsuhs.edu,Baojin.Ding@lsuhs.edu,"matthew.woolard@lsuhs.edu,temitayo.bamgbose@lsuhs.edu, oluwakemi.igiehon@lsuhs.edu, Zachariah.martin@lsuhs.edu",huichao.lee@lsuhs.edu,arif.yurdagul@lsuhs.edu,METH vs Saline,"nicholas.First@lsuhs.edu, katelyn.parrish@lsuhs.edu, Joel.Goldberg@lsuhs.edu, elham.abdollahi@lsuhs.edu, Monica.cartellegestal@lsuhs.edu",oren.rom@lsuhs.edu,"Jeremy.kamil@lsuhs.edu, madeline.meldrum@lsuhs.edu",camille.cannon@lsuhs.edu,"xiuping.yu@lsuhs.edu, siyuan.cheng@lsuhs.edu","taichiro.nonaka@lsuhs.edu, mohammad.raza@lsuhs.edu, sumit.chatterjee@lsuhs.edu, saima.niti@lsuhs.edu",tarek.mohamed@lsuhs.edu,anamaria.dragoi@lsuhs.edu,nirav.dhanesha@lsuhs.edu,jason.comer@lsuhs.edu	,"xiaohong.lu@lsuhs.edu, Jiyu.li@lsuhs.edu, erika.knott@lsuhs.edu, clifton.haacker@lsuhs.edu, katelyn.lofton@lsuhs.edu",mabruka.alfaidi@lsuhs.edu,"rohit.jangra@lsuhs.edu, cierra.word@lsuhs.edu, nahomi.guerra@lsuhs.edu, ridwan.arinola@lsuhs.edu, ramandeep.kaur@lsuhs.edu, upendra.lambe@lsuhs.edu",-,Hongyan.guo@lsuhs.edu,"wayne.orr@lsuhs.edu, syrine.bendhaoudumitrescu@lsuhs.edu, matthew.scott@lsuhs.edu, brenna.pearsongallion@lsuhs.edu, Gerardo.Marquez@lsuhs.edu",zithlaly.amezquita@lsuhs.edu,"ricaurte.marquezortiz@lsuhs.edu, Bilkis.Akhter@lsuhs.edu, nibedita.aich@lsuhs.edu, morgan.bradford@lsuhs.edu, krista.rodgers@lsuhs.edu","adesewa.akande@lsuhs.edu,deirdre.thornton@lsuhs.edu,hyung.nam@lsuhs.edu","Katarzyna.Zwolinska@lsuhs.edu, timothy.keiffer@lsuhs.edu, anand.kushwaha@lsuhs.edu, Mireya.peresaperez@lsuhs.edu, Piotr Naporowski","diana.cruz@lsuhs.edu, analilia.garza@lsuhs.edu","ActivatedCTL BB vs ActivatedCTL RB,CD44CD4p BB vs CD44CD4p RB,Cluster0 BB vs Cluster0 RB,Th17 BB vs Th17 RB,Treg BB vs Treg RB",-,bo.wood@lsuhs.edu,frances.vest@lsuhs.edu,"ScrRNA vs siODC, siODC vs siMYOCD, ScrRNA vs siMYOCD, Scr-GFP vs siODC-GFP, siODC-GFP vs siODC-MYOCD, Scr-GFP vs siODC-MYOCD","siOvsscr,siMYOvsscr,siO_MYOCDvssiO_GFP",EBV+ to EBV-negative carcinoma cells,"WT 1dpi vs mock, WT 1 dpi vs WT + IFN-B, STAT1 1 dpi vs WT 1 dpi, STAT1 3 dpi vs WT 3 dpi, STAT1 5 dpi vs WT 5 dpi, IFNAR2 1 dpi vs WT 1 dpi, IFNAR2 3 dpi vs WT 3 dpi, IFNAR2 5 dpi vs WT 5 dpi","andrew.yurochko@lsuhs.edu, ifeoluwa.ogungbemi@lsuhs.edu, joseph.eniafe@lsuhs.edu, Victoria.Filloon@lsuhs.edu, byeongjae.lee@lsuhs.edu, Jamal.Inusah@lsuhs.edu",mock vs siNDRG2,xuemei.zong@lsuhs.edu,We will compare endometriosis versus healthy and endometriosis versus other diseases,"Phosphosites_HCMVvsMockï¼Œ Phosphosites_HCMVvsMock_30mï¼ŒPhosphosites_HCMVvsMock_2hï¼Œ Phosphosites_HCMVvsMock_24hï¼ŒPhosphosites_HCMVvsMock_72h, Unphosphosites_HCMVvsMockï¼Œ Unphosphosites_HCMVvsMock_30mï¼ŒUnphosphosites_HCMVvsMock_2hï¼Œ Unphosphosites_HCMVvsMock_24hï¼ŒUnphosphosites_HCMVvsMock_72h",-,"BB0870 vs RB50, BB0931 vs RB50",Charles.Levy@lsuhs.edu,"Group A vs Group B, Group C vs Group D, Group E vs Group F, Group A vs Group C, Group A vs Group E, Group B vs Group D, Group B vs Group E","Group A vs Group C, Group B vs Group D, Group A vs Group B, Group C vs Group D
",vesna.tesic@lsuhs.edu,"13vs16; 10vs14; 10, 13 vs 14, 16",-,Groupe D vs B; Groupe F vs B and Groupe B vs A,"HPV+EBV+ vs HPV+EBV-, HPV-EBV+ vs HPV-EBV-, HPV+EBV+ vs HPV-EBV+","In Astrocytes: 45%HFD vs NFD, 45%HFD+BCAS vs NFD+BCAS, NFD+BCAS vs NFD, 45% HFD+BCAS vs 45% HFD; In Microglias: 45%HFD vs NFD, 45%HFD+BCAS vs NFD+BCAS, NFD+BCAS vs NFD, 45% HFD+BCAS vs 45% HFD",Victoria.bradford@lsuhs.edu,omar.francocoronel@lsuhs.edu,treated (n=8) vs control (n=8),Only one group,"DEG: Group D vs Group C, Group B vs Group A, Group D vs Group B, Group C vs Group A; Pathway analysis: Group D vs Group C",Group B vs Group A,Group B vs group A,Group B vs Group A,"BBM-BALBC vs RB50-BALBC, BBM-GATA vs RB50-GATA","PH1vsCTL, PH2vsCTL, PH3vsCTL, PH2vsPH1, PH3vsPH1, PH3vsPH2; PH1vsCTL, PH1_B6vsCTL, PH2vsCTL, PH3vsCTL, PH1_B6vsPH1, PH2vsPH1, PH3vsPH1, PH2vsPH1_B6, PH3vsPH1_B6, PH3vsPH2","D vs A,E vs B,F Vs C,B vs A,C vs A","F_Liver_KOvsWT, F_Plasma_KOvsWT, M_Liver_KOvsWT, M_Plasma_KOvsWT",Control VS Irr,Stroke Vs Sham,-,"G2 vs G1, G4 vs G3, G6 vs G5",-,Group D vs Group C,christopher.pattillo@lsuhs.edu,"WT vs. deltaABD2, deltaABD2 vs. 3A-1",-,Shaghayegh Akbari <sak001@lsuhs.edu>,-,-,As per discussion,"Group A vs. Group B, Group C vs. Group D",treatment,Group 3 vs Group 4\nGroup 3 vs Group 1\nGroup 1 vs Group 2\nGroup 3 vs Group 5\nGroup 2 vs Group 5
76e3ee51,Expected Completion Time,2023-10-10,2023-10-31,2023-09-22,2023-09-20,-,2023-10-16,2023-11-03,2023-10-27,-,2023-11-20,2023-11-30,2023-12-10,-,2023-12-22,2023-12-22,2024-01-05,2023-12-31,2024-02-02,-,2024-02-15,2024-02-29,-,2024-03-21,-,2024-04-01,-,-,-,2025-03-06,-,-,-,-,2024-04-01,2025-04-07,-,2024-03-13,-,2024-04-01,2025-04-01,2025-03-31,2024-03-20,2024-03-31,2024-03-27,2024-04-01,-,2024-04-02,2024-03-22,-,-,2024-04-04,-,-,-,2024-04-01,2024-05-03,2024-05-03,-,2024-05-09,2024-04-01,2024-06-10,-,-,-,-,-,2024-07-29,2024-08-07,2024-08-07,2024-08-03,2024-08-08,2024-08-13,2024-08-21,2024-11-05,2024-10-30,2024-09-19,2024-09-26,-,2024-10-14,2024-10-18,2024-10-18,2024-10-18,2024-10-11,-,2024-11-18,2024-11-08,2024-11-08,2024-11-06,2024-11-14,-,2024-11-30,2024-11-13,2024-11-15,2024-12-05,2025-01-03,2025-01-03,2024-12-26,2025-01-03,-,2025-01-31,2025-01-24,2025-01-25,2025-02-19
000f4257,Questions and Special Requirments ,-,I would like to discuss the project as questions come up,-,-,-,"Discussion after the end of the analysis would be appreciated, thank you!",-,We weren't sure what to put for expected completion date. We just put a week from todays submission date. ,-,none at the moment,We discuss with pesonal as project goes.,-,-,"The raw counts file has the following extra sample counts: 1FBS.1_S13, X1FBS.2_S14, X1FBSEphrinA1.24h.1_S17, X1FBSEphrinA1.24h.2_S18, X1FBSEphrinA1.6h.1_S15, X1FBSEphrinA1.6h.2_S16, Ad.EphA2.72hSF.1_S4, Ad.EphA2.72hSF.2_S5, Ad.EphA2.72hSF.3_S6, Ad.GFP.72hSF.1_S1, Ad.GFP.72hSF.2_S2, Ad.GFP.72hSF.3_S3, \n\nThose may all be removed from the analysis, as they are part of another experiment but was run on the same cartridge as the mock/siEphA2 samples.",-,none,I would like to discuss the project as questions come up.,"There are other samples included in this dataset which may be analyzed in the future:
GTFMock, NDRMock, siGTF2i,siNDRG2
",-,Thank you for your help!,-,-,"[""We would like BioRender licenses--- by the way, I think you guys should use a different intake form for this type of item since many questions don't apply.""]",-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,"There are 2 fastq files per virus strain. SeqCoast says that there are 2 files per sample for paired-end reads. If you need more information, please let me know. Thank you!",-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,-,Please let me know when to send the file,Hoping to create a pipeline and analysis platform for current and future experiments,-,-,-,-,-,-,-,-,-,-,"Need to discuss in-person to explain group comparison, gene of interest",-,-,-,"[""Hello,\nLauren Henderson in Dr Kamil's lab has ordered a similar service from you in the past. I hope that helps to clarify my request.""]",I just received the data; Im aploading them one by one. Can you please keep the project name as it is right now? Thank you very much.,-,-,-,-,-,-,-,"Hi, Iwill share the Data tomorrow with you",-,Special requirements may be needed based on the initial analysis results.  ,-,-,-,-,Please contact us (linda.rubiorubio@lsuhs.edu; dsg001@lsuhs.edu) if you have any questions during the course of this analysis.,Please feel free to contact us (linda.rubiorubio@lsuhs.edu; dsg001@lsuhs.edu) with any questions.,-,-,-,-,-,-,-
